Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/2/2025

Onset of Action and Efficacy of Famotidine

Pharmacodynamic Properties

  • The American Gastroenterological Association notes that intramuscular administration of famotidine provides approximately 6 hours of acid suppression 2

Clinical Context and Efficacy

  • The American College of Gastroenterology recommends that PPIs are more effective than H2-receptor antagonists, including famotidine, for treating esophageal GERD syndromes and healing esophagitis 3
  • For short-term symptom relief or on-demand therapy, famotidine's rapid onset makes it useful when immediate effect is needed, as suggested by the American Gastroenterological Association 3

Important Clinical Considerations

  • The American Heart Association suggests that patients on dual antiplatelet therapy should receive famotidine instead of PPIs, as famotidine does not interfere with clopidogrel's antiplatelet activity 2
  • The American College of Gastroenterology notes that all H2-receptor antagonists, including famotidine, develop tachyphylaxis within 6 weeks of continuous use, significantly limiting their effectiveness for long-term therapy 2
  • Standard-dose famotidine is ineffective for preventing NSAID-related gastric ulcers, though it reduces duodenal ulcers, as reported by the American Gastroenterological Association 4

REFERENCES

1

Intramuscular Famotidine Administration [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Gastritis Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025